Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 12/31/2020

Performance data quoted represents past performance, which does not guarantee future results. Current performance may differ from figures shown. Investment return and principal value will fluctuate with market conditions, and you may have a gain or a loss when you sell your shares.
Month EndAs of 12/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 30.22 14.15 8.03 17.42 12.02
Fund with Sales Charge (%) (POP) 30.22 14.15 8.03 17.42 12.02
NASDAQ Biotechnology Index (%) 25.69 12.34 6.09 17.34 12.26
S&P 500 Index (%) 18.40 14.18 15.21 13.88 8.25
Quarter EndAs of 12/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 30.22 14.15 8.03 17.42 12.02
Fund with Sales Charge (%) (POP) 30.22 14.15 8.03 17.42 12.02
NASDAQ Biotechnology Index (%) 25.69 12.34 6.09 17.34 12.26
S&P 500 Index (%) 18.40 14.18 15.21 13.88 8.25

After-Tax Average Annual Total Returns [further-information] As of 12/31/2020

No chart available for this data.
Month EndAs of 12/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold
Fund without Sales Charge (%) (NAV) After Shares Sold
Fund with Sales Charge (%) (POP) Before Shares Sold
Fund with Sales Charge (%) (POP) After Shares Sold
No chart available for this data.
Quarter EndAs of 12/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold
Fund without Sales Charge (%) (NAV) After Shares Sold
Fund with Sales Charge (%) (POP) Before Shares Sold
Fund with Sales Charge (%) (POP) After Shares Sold

Calendar Year Returns

Performance data quoted represents past performance, which does not guarantee future results. Current performance may differ from figures shown. Investment return and principal value will fluctuate with market conditions, and you may have a gain or a loss when you sell your shares.
2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Fund without Sales Charge (%) (NAV) 30.22 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65
Fund with Sales Charge (%) (POP) 30.22 35.19 -15.51 19.10 -16.96 5.75 34.28 69.15 29.72 8.65
NASDAQ Biotechnology Index (%) 25.69 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08
S&P 500 Index (%) 18.40 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11

Cumulative Total Returns [further-information] As of 12/31/2020

Performance data quoted represents past performance, which does not guarantee future results. Current performance may differ from figures shown. Investment return and principal value will fluctuate with market conditions, and you may have a gain or a loss when you sell your shares.
Month EndAs of 12/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 10.91 30.22 30.22 48.74 47.12 398.06 1,305.52
Fund with Sales Charge (%) (POP) 10.91 30.22 30.22 48.74 47.12 398.06 1,305.52
NASDAQ Biotechnology Index (%) 11.80 25.69 25.69 41.78 34.42 395.06 1,379.50
S&P 500 Index (%) 12.15 18.40 18.40 48.85 103.04 267.00 533.28
Quarter EndAs of 12/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 10.91 30.22 30.22 48.74 47.12 398.06 1,305.52
Fund with Sales Charge (%) (POP) 10.91 30.22 30.22 48.74 47.12 398.06 1,305.52
NASDAQ Biotechnology Index (%) 11.80 25.69 25.69 41.78 34.42 395.06 1,379.50
S&P 500 Index (%) 12.15 18.40 18.40 48.85 103.04 267.00 533.28

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 12/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 24.06 25.00 23.15
Standard Deviation (NASDAQ Biotechnology Index) 22.76 23.32 21.29
Beta 1.02 1.04 1.05
Sharpe Ratio 0.53 0.28 0.73
Information Ratio 0.28 0.32 0.01
Tracking Error 6.41 6.01 6.22

ADDITIONAL RISK STATISTICSAs of 12/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 0.96 0.93 1.03
Beta Bear 1.03 1.05 1.04
Bull Bear Capture Ratio 1.06 1.09 1.01
Gains/Losses 1.63 1.37 1.82

SALES CHARGE, EXPENSES & FEES As of 09/01/2020 (updated annually)

Gross Expense Ratio 0.80%
Net Expense Ratio [further-information] 0.78%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 12/31/2020 Updated Monthly, based on a 3-year period

Beta 1.02
Sharpe Ratio 0.53
Standard Deviation 24.06

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index